SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Abuckatatime who wrote (28659)4/6/1999 8:09:00 PM
From: Cacaito  Read Replies (1) of 32384
 
Hypthyroidism is a serious side effect, but in a patient with the burden of CTCL it will be easy to replace thyroid hormones if Targretin actually work.

It was also related to high doses. How many patients will need this doses? Probably not many of them, Maybe this were patients in end stages of CTCL needing high doses?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext